Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization
Author(s) -
Patrizio Pascale,
J. Schlaepfer,
Mauro Oddo,
MarieDenise Schaller,
P Vogt,
Martin Fromer
Publication year - 2009
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eup314
Subject(s) - medicine , cardiology , ejection fraction , coronary artery disease , ventricular tachycardia , myocardial infarction , sudden cardiac death , ventricular fibrillation , sudden death , atrial fibrillation , implantable cardioverter defibrillator , heart failure
Estimates of the left ventricular ejection fraction (LVEF) in patients with life-threatening ventricular arrhythmias related to coronary artery disease (CAD) have rarely been reported despite it has become the basis for determining patient's eligibility for prophylactic defibrillator. We aimed to determine the extent and distribution of reduced LVEF in patients with sustained ventricular tachycardia or ventricular fibrillation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom